featured
Phase VI KEYNOTE-B10: Pembrolizumab Plus Carboplatin Plus Paclitaxel as First-line Therapy in R/M HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: